Prevalensi Antibodi IgG dan DNA Cytomegalovirus pada darah donor di unit transfusi darah Provinsi DKI Jakarta
Abstract
Indonesia has not conduct regular screening test of CMV infection due to the lack of seropositive prevelance data information. However, seronegative CMV results is not an indicator of safe blood for transfusion, so that another test that serves as confirmation test for CMV DNA is required. The aim of this study is to obtain prevalence data of CMV IgG antibody positive, the prevalence of CMV DNA positive and to determine the effect of CMV IgG titers against CMV DNA in blood donors in UTD PMI DKI Jakarta. Cross-sectional method was used to test 113 blood donor samples which have met inclusion criteria. Screening for CMV IgG antibody was held using indirect method chemiluminescence immunoassay (ChLIA) by Liason® XL 10050 Chemiluminescence Analyzer and CMV DNA analysis using qPCR method for the detection of CMV UL 54 with a tool Roche Light Cycler 480 II. Results indicate positive prevalence of IgG CMV in 111 samples (98.23%), and negative CMV IgG in 2 samples (1.77%). Prevalence of CMV DNA positive donors is one sample (0.88%), 112 negative CMV DNA samples (99.12%) and Fisher's test results {P (0.982)> α (0.05)} showed no significant association between CMV IgG status with CMV DNA. CONCLUSIONS: UTD DKI Jakarta has a high prevalence of CMV IgG with low prevalence of CMV DNA.
References
Abdelrazik AM, Ahmed GME. Priority needs and wisdom strategy for blood transfusion safety in developing low-resource countries. Transci.2016;54:147–9
WHO. Screening donated blood for transfusion-transmissible infections: recommendations.[Internet].2010 [tanggal akses 2 juli 2016], didapat dari: http://www.who.int/ bloodsafety/ScreeningTTI .pdf
Rampengan NH. Diagnosis Infeksisitomegalovirus Pada Bayi Dan Anak. JBM.2015;7(3): 137-143
Eivazi-Ziaei J, Movassagpour A, Asgharzadeh M, Dastgiri S. Seroprevalence of cytomegalovirus in blood donors in the northwest of Iran. J Analyt Res Clin Med 2013; 1(2): 96-100.
Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA et al. Fields virology.6th Edition.Philadelphia: Lippincott Williams & Wilkins.2013; 2 :1960-2010
Griffiths P, Baraniak I, Reeves M. The Pathogenesis of Human Cytomegalovirus. J Pathol.2015;235:288-97
Njeru D.G, Mwanda W.O, Kitonyi G.W, Njagi E. C. Prevalence Of Cytomegalovirus Antibodies In Blood Donors At The National Blood Transfusion Centre, Nairobi.EAMJ.2009; 86:S58-61
Shaiegan M, Rasouli M, Zadsar M, Zolfaghari S. Meta-analysis of Cytomegalovirus seroprevalence in volunteer blood donors and healthy subjects in Iran from 1992 to 2013. Iran J Basic Med Sci. 2015;18(7):627-34.
Gugun AM. Prevalensi Seropositif IgM/IgG Cytomegalovirus pada Populasi Wanita Pra-nikah dengan Riwayat Konsumsi Makan Lesehan. Mutiara Medika.2012;12(2):124-131
American Associated Blood Banking. Technical Manual.18th ed. United State: AABB;2014:97-104
Kumar H, Gupta PK, Mishra DK, Jaiprakash M. Leucodepletion and Blood Product. MJAFI.2006;62(2):174-177
Ziemann M, Hennig H. Prevention of transfusion transmitted Cytomegalovirus infection: which is the optimal strategy?.Transfus Med Hemother.2014;41:40-44.
Qu L, Tran M H. Cytomegalovirus and Transfusion Medicine. Blood Buletin. 2007;9(1):1-2
Bianchi M, Vaglio S, Pupella S, Marano G,Facco G, M Giancarlo et al. Leucoreduction of blood komponen an effective way to increase blood safety?.BloodTransfus. 2016;14:214-27
Pusat data dan informasi kemenkes RI. Situasi donor darah di Indonesia. Bulletin data dan informasi kesehatan Kementerian Kesehatan RI. 2014.1-14
UTD PMI Provinsi DKI Jakarta. Laporan Penggunaan PRC leukodepleted Tahun 2015.Jakarta:UTD PMI DKI Jakarta;2015
Kit Insert LIAISON®CMV IgG II ([REF] 310745).Diasorin [Internet].2012 [tanggal akses 18 September 2016], didapat dari : http://www. diasorin.com/en/liaisonr-cmv-igg-ii
Ariyanto IA. Peran Infeksi CMV Terhadap Profil sel Limfosit T dan sel Natural Killer pada Pasien HIV Yang Memulai ART di Jakarta [Tesis]. Jakarta: Ilmu Biomedik FKUI; 2016:47-9
Kit Insert QIAamp® DNA Mini and Blood Mini Handbook.Third edition.Qiagen [Internet].2012. [tanggal akses 18 September 2016], didapat dari : https://moodle.ufsc.br/pluginfile.php/1379318/mod_resource/content/0/ QIAamp_DNA_Mini _Blood.pd
Ligozzi M, PoggiM,Saletti M, Gibellini D.Development of a real-time quantitative polymerase chain reactionassay for the detection of congenital human cytomegalovirus infectionin urine samples. Mol Cell Probes.2015;30(1):50-2
Ross S.A, Zovak Z, Pati S, Boppana S.B. Diagnosis of Cytomegalovirus Infection. Infect Disord Drug Tragets. 2011;11(5):466-74
de Matos SB, Meyer R, Lima FW. Seroprevalence and serum profile of cytomegalovirus infection among patients withhematologic disorders in Bahia State, Brazil. J Med Virol 2011; 83(2): 298-304.
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010; 20(4): 202-13.
Gargouri J, Elleuch H, Karray H, Rekik H, Hammami A. Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med. 2000; 78(8-9): 512-7.
Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA et al. Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Womens Health.2013;3:423–428.
Kemenkes RI. Ketersediaan darah ditentukan partisipasi masyarakat menjadi donor .[Internet].2016.[tanggal akses 6 Juni 2017], didapat dari :http://www.depkes.go.id/article/ print/16060300001/ketersediaan-darah-ditentu kan-partisipasi-masyarakat-menjadi-donor.html
Habbal W, Monem F, Gartner BC. Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive?.J Clin Microbiol.2009;(58):878–83
Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion. 2007;47:1972-83.
Wills MR, Poole E, Lau B, Krishna B, Sinclair JH. MINI REVIEW.The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?.Cell Mol Immunol.2015;12:128–38
Blut A. Human Cytomegalovirus (HCMV)-Revised*.Tranfus Med Hemother. 2010;37:365-75
Poole E, Wills M, Sinclair J. Review Article. Human Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection. Hindawi Publishing Corporation. ScientificWorldJournal. 2014:1-10
Goldman L, Schafer AI. Goldman-Cecil Medicine. Elsevier Health Sciences; 2015.
Lisyani Bs. Kewaspadaan Terhadap Infeksi Cytomegalovirus Serta Kegunaan Deteksi Secara Laboratorik. Pidato Pengukuhan Guru Besar Universitas Dipenogoro. 2007
Cervia JS, Wenz B, Ortolano GA.Leukocyte Reduction’s Role in the Attenuation of Infection Risks among Transfusion Recipients. Clin Infect Dis. 2007;45:1008-13.
Sakiani S, Koh C, Heller T. Understanding the Presence of False-Positive Antibodies in Acute Hepatitis. JID. 2014;210:1886–9.
Zhang S, Zhou YH, Li L, Hu Y. Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR. VirologyJ.2010;7:73
WHO.Global database on blood safety [Internet].2014. .[tanggal akses 6 Juni 2017], didapat dari :http://www.who.int/ bloodsafety /global_database/html.
Breda G, Almeida B, Carstensen S, Bonfim CM, Nogueira MB, Vidal LD et al. Human cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries. Pathogens and Global Health.2013;107(6):312-319.
Copyright (c) 2017 JHECDs: Journal of Health Epidemiology and Communicable Diseases
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
